deoxycytidine has been researched along with Cancer of Jaw in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bier, J; Gath, HJ; Oettle, H; Raguse, JD; Riess, H | 1 |
1 other study(ies) available for deoxycytidine and Cancer of Jaw
| Article | Year |
|---|---|
Cilengitide (EMD 121974) arrests the growth of a heavily pretreated highly vascularised head and neck tumour.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Deoxycytidine; Facial Neoplasms; Gemcitabine; Humans; Jaw Neoplasms; Male; Middle Aged; Snake Venoms | 2004 |